cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15131/shef.data.12328226.v30
title: CoVid Plots and Analysis

description: # COVID-19Plots and analysis relating to the coronavirus pandemic. Includes five sets of plots and associated R code to generate them.1) HeatmapsUpdated every few days - heatmaps of COVID-19 case and death trajectories for Local Authorities (or equivalent) in England, Wales, Scotland, Ireland and Germany.2) All cause mortalityUpdated on Tuesday (for England & Wales), Wednesday (for Scotland) and Friday (for Northern Ireland) - analysis and plots of weekly all-cause deaths in 2020 compared to previous years by country, age, sex and region. Also a set of international comparisons using data from mortality.org3) ExposuresNo longer updated - mapping of potential COVID-19 mortality exposure at local levels (LSOAs) in England based on the age-sex structure of the population and levels of poor health.There is also a Shiny app which creates slightly lower resolution versions of the same plots online, which you can find here: https://victimofmaths.shinyapps.io/covidmapper/, on GitHub https://github.com/VictimOfMaths/COVIDmapper and uploaded to this record4) Index of Multiple Deprivation No longer updated - preliminary analysis of the inequality impacts of COVID-19 based on Local Authority level cases and levels of deprivation. 5) Socioeconomic inequalities. No longer updated (unless ONS release more data) - Analysis of published ONS figures of COVID-19 and other cause mortality in 2020 compared to previous years by deprivation decile.<br>Latest versions of plots and associated analysis can be found on Twitter: https://twitter.com/victimofmaths<br>This work is described in more detail on the UK Data Service Impact and Innovation Lab blog: http://lab.ukdataservice.ac.uk/2020/05/21/visualising-high-risk-areas-for-covid-19-mortality/<br>Adapted from data from the Office for National Statistics licensed under the Open Government Licence v.1.0.http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/<br>
DOI: 10.15468/dl.t3dz8p
title: Occurrence Download

description: A dataset containing 2251 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bacidia fraxinea"
 ]
}

 The dataset includes 2251 records from 70 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010673-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.29558294
title: Supplementary Material for: Half-dose anticoagulation versus antiplatelet therapy to reduce silent cerebral embolism after left atrial appendage occlusion (HALO-SCE study): Rationale and design of a randomized clinical trial

description: Introduction: Patients with atrial fibrillation (AF) continue to face thrombotic risks even after the left atrial appendages (LAA) have been occluded, which may manifest as silent cerebral embolisms (SCEs). Half-dose anticoagulation (Hd-OAC) is a pathophysiologically more reasonable therapy in addressing this issue than antithrombotic therapy, but it still lacks strong evidence.
Methods: The trial (NCT05671276) is a multicenter, randomized controlled trial comparing the efficacy of two antithrombotic strategies (Hd-OAC therapy vs. standard antithrombotic therapy) in AF patients after left atrial appendages occlusion (LAAO). The primary endpoint is the incidence of newly detected SCEs on any magnetic resonance imaging conducted during the follow-up period. The secondary endpoints are (1) more than two new SCEs during the follow-up, their size and distribution, (2) cognitive function, and (3) a composite endpoint of all-cause mortality, clinical thromboembolic events, and major bleeding events. Follow-up is scheduled at 90±15 days, 180±15 days, and 365±15 days after LAAO. 
Conclusions: This trial aims to determine whether Hd-OAC therapy can reduce the incidence of SCE and protect cognitive function in patients who have successfully undergone LAAO, compared to standard antithrombotic therapy.
Trial Registration: ClinicalTrials.gov: NCT05671276.
DOI: 10.6084/m9.figshare.29558294.v1
title: Supplementary Material for: Half-dose anticoagulation versus antiplatelet therapy to reduce silent cerebral embolism after left atrial appendage occlusion (HALO-SCE study): Rationale and design of a randomized clinical trial

description: Introduction: Patients with atrial fibrillation (AF) continue to face thrombotic risks even after the left atrial appendages (LAA) have been occluded, which may manifest as silent cerebral embolisms (SCEs). Half-dose anticoagulation (Hd-OAC) is a pathophysiologically more reasonable therapy in addressing this issue than antithrombotic therapy, but it still lacks strong evidence.
Methods: The trial (NCT05671276) is a multicenter, randomized controlled trial comparing the efficacy of two antithrombotic strategies (Hd-OAC therapy vs. standard antithrombotic therapy) in AF patients after left atrial appendages occlusion (LAAO). The primary endpoint is the incidence of newly detected SCEs on any magnetic resonance imaging conducted during the follow-up period. The secondary endpoints are (1) more than two new SCEs during the follow-up, their size and distribution, (2) cognitive function, and (3) a composite endpoint of all-cause mortality, clinical thromboembolic events, and major bleeding events. Follow-up is scheduled at 90±15 days, 180±15 days, and 365±15 days after LAAO. 
Conclusions: This trial aims to determine whether Hd-OAC therapy can reduce the incidence of SCE and protect cognitive function in patients who have successfully undergone LAAO, compared to standard antithrombotic therapy.
Trial Registration: ClinicalTrials.gov: NCT05671276.
DOI: 10.15131/shef.data.12328226.v31
title: CoVid Plots and Analysis

description: # COVID-19Plots and analysis relating to the coronavirus pandemic. Includes five sets of plots and associated R code to generate them.1) HeatmapsUpdated every few days - heatmaps of COVID-19 case and death trajectories for Local Authorities (or equivalent) in England, Wales, Scotland, Ireland and Germany.2) All cause mortalityUpdated on Tuesday (for England & Wales), Wednesday (for Scotland) and Friday (for Northern Ireland) - analysis and plots of weekly all-cause deaths in 2020 compared to previous years by country, age, sex and region. Also a set of international comparisons using data from mortality.org3) ExposuresNo longer updated - mapping of potential COVID-19 mortality exposure at local levels (LSOAs) in England based on the age-sex structure of the population and levels of poor health.There is also a Shiny app which creates slightly lower resolution versions of the same plots online, which you can find here: https://victimofmaths.shinyapps.io/covidmapper/, on GitHub https://github.com/VictimOfMaths/COVIDmapper and uploaded to this record4) Index of Multiple Deprivation No longer updated - preliminary analysis of the inequality impacts of COVID-19 based on Local Authority level cases and levels of deprivation. 5) Socioeconomic inequalities. No longer updated (unless ONS release more data) - Analysis of published ONS figures of COVID-19 and other cause mortality in 2020 compared to previous years by deprivation decile.<br>Latest versions of plots and associated analysis can be found on Twitter: https://twitter.com/victimofmaths<br>This work is described in more detail on the UK Data Service Impact and Innovation Lab blog: http://lab.ukdataservice.ac.uk/2020/05/21/visualising-high-risk-areas-for-covid-19-mortality/<br>Adapted from data from the Office for National Statistics licensed under the Open Government Licence v.1.0.http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/<br>
DOI: 10.6084/m9.figshare.29558297
title: Supplementary Material for: Palliative radiotherapy for multiple liver metastases of Merkel cell carcinoma: A case report

description: Introduction:
There have been few reports of the efficacy of palliative radiotherapy (RT) for liver metastases of Merkel cell carcinoma (MCC). A case of a patient with gastrointestinal symptoms and liver dysfunction caused by multiple liver metastases of MCC is presented. Palliative RT improved the symptoms and liver function, enabling the continuation of systemic therapy.
Case Presentation:
A 66-year-old woman presented with metastatic MCC. Palliative RT (20 Gy in 5 fractions) was administered to the metastases extending from thoracic vertebra 11 to lumbar vertebra 1, and metastases in the left lobe of the liver were unintentionally partially included in the irradiation field. After palliative RT, avelumab therapy was initiated, but she complained of nausea and loss of appetite. Subsequent evaluations showed liver dysfunction and rapid progression of liver metastases. Palliative RT (20 Gy in 5 fractions) was administered to the right lobe of the liver, avoiding overlap with the previously irradiated area.
Two weeks after RT, the patient showed significant improvement of the symptoms and liver function. The patient experienced no significant adverse events. She continued avelumab treatment, but she died two months after palliative RT to the right lobe of the liver due to progression of the MCC.
Conclusion:
Palliative RT should be considered a treatment option for patients with MCC who develop symptomatic liver metastases.
DOI: 10.6084/m9.figshare.29558297.v1
title: Supplementary Material for: Palliative radiotherapy for multiple liver metastases of Merkel cell carcinoma: A case report

description: Introduction:
There have been few reports of the efficacy of palliative radiotherapy (RT) for liver metastases of Merkel cell carcinoma (MCC). A case of a patient with gastrointestinal symptoms and liver dysfunction caused by multiple liver metastases of MCC is presented. Palliative RT improved the symptoms and liver function, enabling the continuation of systemic therapy.
Case Presentation:
A 66-year-old woman presented with metastatic MCC. Palliative RT (20 Gy in 5 fractions) was administered to the metastases extending from thoracic vertebra 11 to lumbar vertebra 1, and metastases in the left lobe of the liver were unintentionally partially included in the irradiation field. After palliative RT, avelumab therapy was initiated, but she complained of nausea and loss of appetite. Subsequent evaluations showed liver dysfunction and rapid progression of liver metastases. Palliative RT (20 Gy in 5 fractions) was administered to the right lobe of the liver, avoiding overlap with the previously irradiated area.
Two weeks after RT, the patient showed significant improvement of the symptoms and liver function. The patient experienced no significant adverse events. She continued avelumab treatment, but she died two months after palliative RT to the right lobe of the liver due to progression of the MCC.
Conclusion:
Palliative RT should be considered a treatment option for patients with MCC who develop symptomatic liver metastases.
DOI: 10.15468/dl.pzmryt
title: Occurrence Download

description: A dataset containing 69 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Agave americana",
 "Country is Rwanda",
 "HasCoordinate is true"
 ]
}

 The dataset includes 69 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010678-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.29558300
title: Supplementary Material for: The Effects of Digital Cognitive Behavioral Therapy for Insomnia in Chronic Pain: A Randomized Controlled Trial

description: Introduction. Managing chronic pain is a significant healthcare challenge requiring a multimodal approach. The frequent presence of comorbid insomnia and its bidirectional relationship with pain complicates treatment. This study tested whether adding digital cognitive behavioral therapy for insomnia (dCBT-I) to standard chronic pain treatment improves symptoms compared to a waitlist control (WLC).

Methods. Participants with chronic pain and insomnia were randomized (1:1) to dCBT-I or WLC. Assessments occurred at baseline, eight, and 24 weeks post-randomization. The primary outcome was insomnia severity (Insomnia Severity Index; ISI). Secondary outcomes included sleep- and pain-related symptoms, well-being, and dreams. Linear mixed models assessed between-group differences.

Results. A total of 207 participants (182 women, mean age=51.96±12.97 years) were randomized to dCBT-I (n=103) or WLC (n=104). The dCBT-I group showed large improvements in insomnia severity versus WLC at both eight (-4.36, p&lt;.001; d=-1.18) and 24 weeks (-4.88, p&lt;.001; d=-1.32). Pain-related impairments and life control also improved, favoring dCBT-I (ds=0.22–0.35). Moderate-to-large effects were observed for secondary outcomes, including daytime sleepiness, fatigue, and dysfunctional sleep beliefs (ds=0.47-1.12).

Conclusion. dCBT-I effectively reduces insomnia severity in individuals with chronic pain and insomnia. Improvements in chronic pain symptoms highlight its potential as a scalable, evidence-based intervention for multimodal pain management.
DOI: 10.6084/m9.figshare.29558300.v1
title: Supplementary Material for: The Effects of Digital Cognitive Behavioral Therapy for Insomnia in Chronic Pain: A Randomized Controlled Trial

description: Introduction. Managing chronic pain is a significant healthcare challenge requiring a multimodal approach. The frequent presence of comorbid insomnia and its bidirectional relationship with pain complicates treatment. This study tested whether adding digital cognitive behavioral therapy for insomnia (dCBT-I) to standard chronic pain treatment improves symptoms compared to a waitlist control (WLC).

Methods. Participants with chronic pain and insomnia were randomized (1:1) to dCBT-I or WLC. Assessments occurred at baseline, eight, and 24 weeks post-randomization. The primary outcome was insomnia severity (Insomnia Severity Index; ISI). Secondary outcomes included sleep- and pain-related symptoms, well-being, and dreams. Linear mixed models assessed between-group differences.

Results. A total of 207 participants (182 women, mean age=51.96±12.97 years) were randomized to dCBT-I (n=103) or WLC (n=104). The dCBT-I group showed large improvements in insomnia severity versus WLC at both eight (-4.36, p&lt;.001; d=-1.18) and 24 weeks (-4.88, p&lt;.001; d=-1.32). Pain-related impairments and life control also improved, favoring dCBT-I (ds=0.22–0.35). Moderate-to-large effects were observed for secondary outcomes, including daytime sleepiness, fatigue, and dysfunctional sleep beliefs (ds=0.47-1.12).

Conclusion. dCBT-I effectively reduces insomnia severity in individuals with chronic pain and insomnia. Improvements in chronic pain symptoms highlight its potential as a scalable, evidence-based intervention for multimodal pain management.
DOI: 10.15468/dl.28rx74
title: Occurrence Download

description: A dataset containing 211 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Hemiculter bleekeri"
 ]
}

 The dataset includes 211 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010674-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.fvmr9h
title: Occurrence Download

description: A dataset containing 416 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Berberis montana"
 ]
}

 The dataset includes 416 records from 58 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010675-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.6k8yzx
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Agave americana",
 "Country is Palau",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010676-250711103210423/datasets/export for details.
DOI: 10.15468/dl.6ewyqc
title: Occurrence Download

description: A dataset containing 3081 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Agave americana",
 "Country is Portugal",
 "HasCoordinate is true"
 ]
}

 The dataset includes 3081 records from 19 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010677-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15131/shef.data.12328226.v32
title: CoVid Plots and Analysis

description: # COVID-19Plots and analysis relating to the coronavirus pandemic. Includes five sets of plots and associated R code to generate them.1) HeatmapsUpdated every few days - heatmaps of COVID-19 case and death trajectories for Local Authorities (or equivalent) in England, Wales, Scotland, Ireland and Germany.2) All cause mortalityUpdated on Tuesday (for England & Wales), Wednesday (for Scotland) and Friday (for Northern Ireland) - analysis and plots of weekly all-cause deaths in 2020 compared to previous years by country, age, sex and region. Also a set of international comparisons using data from mortality.org3) ExposuresNo longer updated - mapping of potential COVID-19 mortality exposure at local levels (LSOAs) in England based on the age-sex structure of the population and levels of poor health.There is also a Shiny app which creates slightly lower resolution versions of the same plots online, which you can find here: https://victimofmaths.shinyapps.io/covidmapper/, on GitHub https://github.com/VictimOfMaths/COVIDmapper and uploaded to this record4) Index of Multiple Deprivation No longer updated - preliminary analysis of the inequality impacts of COVID-19 based on Local Authority level cases and levels of deprivation. 5) Socioeconomic inequalities. No longer updated (unless ONS release more data) - Analysis of published ONS figures of COVID-19 and other cause mortality in 2020 compared to previous years by deprivation decile.<br>Latest versions of plots and associated analysis can be found on Twitter: https://twitter.com/victimofmaths<br>This work is described in more detail on the UK Data Service Impact and Innovation Lab blog: http://lab.ukdataservice.ac.uk/2020/05/21/visualising-high-risk-areas-for-covid-19-mortality/<br>Adapted from data from the Office for National Statistics licensed under the Open Government Licence v.1.0.http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/<br>
DOI: 10.17026/ar/slkatm
title: Een langhuis aan de Hoofdstraat 195, Bovenkarspel, gemeente Stede Broec
title: Een archeologische begeleiding en opgraving

description: ADC ArcheoProjecten heeft in het kader van sanering en 
nieuwbouw, een Archeologische begeleiding (AB) en aansluitend een opgraving (DO) uitgevoerd voor het plangebied aan de Hoofdstraat 195 te Bovenkarspel. Het plangebied heeft een oppervlakte van ca. 920 m2, waarvan ca. 250 m2 is opgegraven. Het plangebied wordt begrensd door de Hoofdstraat in het zuiden, een sloot in het noorden en naastgelegen panden in het oosten 
en westen. Voor het plangebied gold een archeologische verwachting op sporen uit de Bronstijd en sporen uit de Volle Middeleeuwen tot en met de Nieuwe Tijd. 
Tijdens de opgraving zijn ophogingslagen van een terp gevonden, die in korte tijd zijn opgeworpen in de periode 1300-1325. In deze fase is ook een ontginningssloot gedempt. Langs de terp lag een terpsloot. In de eerste helft van de 15e eeuw is de terp opnieuw opgehoogd, waarbij de terpsloot gedempt is. Uit deze eerste fasen zijn geen huizen aangetroffen; mogelijk lagen deze ter hoogte van de huidige straat. In de 16e eeuw is de terp aan de noordzijde langer gemaakt en verschijnt het eerste huis binnen het plangebied. Dit is waarschijnlijk een rechthoekig huis op poeren geweest. Mogelijk betreft het houtbouw of vakwerkbouw. In de eerste helft van de 17e eeuw bouwde men een langhuis, met de lange zijde langs de straat (dwarshuis). Dit huis had aan de achterzijde een stalgedeelte, en had een waterput in de keuken en een waterput in de stal. In de tweede helft van de 17e eeuw zijn er aanpassingen gedaan aan het huis. De binnenindeling veranderde en men legde keldertjes aan. De twee waterputten werden vervangen door twee nieuwe in de stal en op het achtererf. In de 18e eeuw bouwde men een waterkelder op het achtererf en legde men een keldertje aan. De verbouwingen uit de 19e en 20e eeuw zijn goed te volgen op de Kadastrale Minuut. 
De materiële cultuur van de bewoners was in de 16e en 17e eeuw zeer rijk aan importen uit Frankrijk, Spanje, Portugal en Italië. De bewoners waren waarschijnlijk betrokken in de zeevaart of hadden connecties met handelaren of zeevarenden. Uit de middeleeuwse vondsten blijkt geen bijzondere of hoge status van de bewoners. Uit de 18e en 19e eeuw was nauwelijks vondstmateriaal aanwezig.
description: ADC Rapport
DOI: 10.15131/shef.data.12328226.v33
title: CoVid Plots and Analysis

description: # COVID-19Plots and analysis relating to the coronavirus pandemic. Includes five sets of plots and associated R code to generate them.1) HeatmapsUpdated every few days - heatmaps of COVID-19 case and death trajectories for Local Authorities (or equivalent) in England, Wales, Scotland, Ireland and Germany.2) All cause mortalityUpdated on Tuesday (for England & Wales), Wednesday (for Scotland) and Friday (for Northern Ireland) - analysis and plots of weekly all-cause deaths in 2020 compared to previous years by country, age, sex and region. Also a set of international comparisons using data from mortality.org3) ExposuresNo longer updated - mapping of potential COVID-19 mortality exposure at local levels (LSOAs) in England based on the age-sex structure of the population and levels of poor health.There is also a Shiny app which creates slightly lower resolution versions of the same plots online, which you can find here: https://victimofmaths.shinyapps.io/covidmapper/, on GitHub https://github.com/VictimOfMaths/COVIDmapper and uploaded to this record4) Index of Multiple Deprivation No longer updated - preliminary analysis of the inequality impacts of COVID-19 based on Local Authority level cases and levels of deprivation. 5) Socioeconomic inequalities. No longer updated (unless ONS release more data) - Analysis of published ONS figures of COVID-19 and other cause mortality in 2020 compared to previous years by deprivation decile.<br>Latest versions of plots and associated analysis can be found on Twitter: https://twitter.com/victimofmaths<br>This work is described in more detail on the UK Data Service Impact and Innovation Lab blog: http://lab.ukdataservice.ac.uk/2020/05/21/visualising-high-risk-areas-for-covid-19-mortality/<br>Adapted from data from the Office for National Statistics licensed under the Open Government Licence v.1.0.http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/<br>